136 related articles for article (PubMed ID: 844905)
1. Evaluation of surface components of Vibrio cholerae as protective immunogens.
Eubanks ER; Guentzel MN; Berry LJ
Infect Immun; 1977 Feb; 15(2):533-8. PubMed ID: 844905
[TBL] [Abstract][Full Text] [Related]
2. Flagella-induced immunity against experimental cholera in adult rabbits.
Yancey RJ; Willis DL; Berry LJ
Infect Immun; 1979 Jul; 25(1):220-8. PubMed ID: 478635
[TBL] [Abstract][Full Text] [Related]
3. Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.
Guentzel MN; Berry LJ
Infect Immun; 1974 Jul; 10(1):167-72. PubMed ID: 4601899
[TBL] [Abstract][Full Text] [Related]
4. Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccine.
Resnick IG; Ford CW; Shackleford GM; Berry LJ
Infect Immun; 1980 Nov; 30(2):375-80. PubMed ID: 7439983
[TBL] [Abstract][Full Text] [Related]
5. Immunity to Vibrio cholerae in the mouse. I. Passive protection of newborn mice.
Pitkin D; Actor P
Infect Immun; 1972 Apr; 5(4):428-32. PubMed ID: 4636782
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.
Attridge SR; Rowley D
J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of lipopolysaccharide on sheathed flagella of Vibrio cholerae O:1 by protein A-gold immunoelectron microscopy.
Fuerst JA; Perry JW
J Bacteriol; 1988 Apr; 170(4):1488-94. PubMed ID: 2450866
[TBL] [Abstract][Full Text] [Related]
8. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
Levinson KJ; De Jesus M; Mantis NJ
Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
[TBL] [Abstract][Full Text] [Related]
9. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
Cryz SJ; Fürer E; Germanier R
Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a flagellar sheath protein of Vibrio cholerae.
Hranitzky KW; Mulholland A; Larson AD; Eubanks ER; Hart LT
Infect Immun; 1980 Feb; 27(2):597-603. PubMed ID: 7380541
[TBL] [Abstract][Full Text] [Related]
12. Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection.
Sinha VB; Jacob A; Srivastava R; Kaper JB; Srivastava BS
Vaccine; 1993; 11(3):372-5. PubMed ID: 8447164
[TBL] [Abstract][Full Text] [Related]
13. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.
Wang Z; Lazinski DW; Camilli A
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795359
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity against Vibrio cholerae infection in the rabbit.
Guinée PA; Jansen WH; Gielen H; Rijpkema SG; Peters PW
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):552-62. PubMed ID: 2964158
[TBL] [Abstract][Full Text] [Related]
15. Motility of the pathogen and intestinal immunity of the host in experimental cholera.
Yancey RJ; Berry LJ
Adv Exp Med Biol; 1978; 107():447-55. PubMed ID: 742500
[TBL] [Abstract][Full Text] [Related]
16. Crossed immunoelectrophoretic analysis of antigenic composition of B-subunit/whole-cell and whole-cell only killed oral cholera vaccines.
Ciznár I; Ahsan CR; Rahman A; Shahabuddin M; Bartková G; Clemens JD; Sack DA
Vaccine; 1992; 10(9):591-6. PubMed ID: 1502836
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
[TBL] [Abstract][Full Text] [Related]
18. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
Losonsky GA; Tacket CO; Wasserman SS; Kaper JB; Levine MM
Infect Immun; 1993 Feb; 61(2):729-33. PubMed ID: 8423098
[TBL] [Abstract][Full Text] [Related]
19. Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.
Cryz SJ; Fürer E; Germanier R
Infect Immun; 1982 Oct; 38(1):21-6. PubMed ID: 7141690
[TBL] [Abstract][Full Text] [Related]
20. Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane.
Richardson K; Parker CD
Infect Immun; 1985 Mar; 47(3):674-9. PubMed ID: 3972446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
